ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-16T4343
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Obesity Drugs Anti obesity Medication Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-Obesity Drugs (Anti-obesity Medication) Market Research Report 2025

Code: QYRE-Auto-16T4343
Report
September 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zafgan
VIVUS
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer Inc
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
Eisai Co Ltd
Boehringer Ingelheim
Bayer
Astrazeneca plc
Arena Pharmaceuticals
Amylin
Alizyme
GlaxoSmithKline
GlaxoSmithKline PLC
F.Hoffmann-La Roche

Anti-Obesity Drugs (Anti-obesity Medication) Market Size

The global market for Anti-Obesity Drugs (Anti-obesity Medication) was valued at US$ 2506 million in the year 2024 and is projected to reach a revised size of US$ 7402 million by 2031, growing at a CAGR of 17.0% during the forecast period.

Anti-Obesity Drugs (Anti-obesity Medication) Market

Anti-Obesity Drugs (Anti-obesity Medication) Market

Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Drugs (Anti-obesity Medication), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Drugs (Anti-obesity Medication).
The Anti-Obesity Drugs (Anti-obesity Medication) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Obesity Drugs (Anti-obesity Medication) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Obesity Drugs (Anti-obesity Medication) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-Obesity Drugs (Anti-obesity Medication) Market Report

Report Metric Details
Report Name Anti-Obesity Drugs (Anti-obesity Medication) Market
Accounted market size in year US$ 2506 million
Forecasted market size in 2031 US$ 7402 million
CAGR 17.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • by Drug Varieties
  • by Acting
Segment by Application
  • Childhood (0-6)
  • Juvenile (7-17)
  • Youth (18-40)
  • Middle Aged (41-60)
  • Elderly (Above 60)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zafgan, Vivus, Shionogi, Sanofi, Rhythm Pharmaceuticals, Pfizer, Orexigen Therapeutics, Novo Nordisk, Norgine, Nalpropion Pharmaceuticals Inc., Merck, GlaxoSmithKline, F.Hoffmann-La Roche, Eisai, Boehringer Ingelheim, Bayer AG, AstraZeneca, Arena Pharmaceuticals, Amylin, Alizyme
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Obesity Drugs (Anti-obesity Medication) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Obesity Drugs (Anti-obesity Medication) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anti-Obesity Drugs (Anti-obesity Medication) Market growing?

Ans: The Anti-Obesity Drugs (Anti-obesity Medication) Market witnessing a CAGR of 17.0% during the forecast period 2025-2031.

What is the Anti-Obesity Drugs (Anti-obesity Medication) Market size in 2031?

Ans: The Anti-Obesity Drugs (Anti-obesity Medication) Market size in 2031 will be US$ 7402 million.

Who are the main players in the Anti-Obesity Drugs (Anti-obesity Medication) Market report?

Ans: The main players in the Anti-Obesity Drugs (Anti-obesity Medication) Market are Zafgan, Vivus, Shionogi, Sanofi, Rhythm Pharmaceuticals, Pfizer, Orexigen Therapeutics, Novo Nordisk, Norgine, Nalpropion Pharmaceuticals Inc., Merck, GlaxoSmithKline, F.Hoffmann-La Roche, Eisai, Boehringer Ingelheim, Bayer AG, AstraZeneca, Arena Pharmaceuticals, Amylin, Alizyme

What are the Application segmentation covered in the Anti-Obesity Drugs (Anti-obesity Medication) Market report?

Ans: The Applications covered in the Anti-Obesity Drugs (Anti-obesity Medication) Market report are Childhood (0-6), Juvenile (7-17), Youth (18-40), Middle Aged (41-60), Elderly (Above 60)

What are the Type segmentation covered in the Anti-Obesity Drugs (Anti-obesity Medication) Market report?

Ans: The Types covered in the Anti-Obesity Drugs (Anti-obesity Medication) Market report are by Drug Varieties, by Acting

1 Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
1.1 Product Definition
1.2 Anti-Obesity Drugs (Anti-obesity Medication) by Type
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value Comparison by Type (2024 VS 2031)
1.2.2 by Drug Varieties
1.2.3 by Acting
1.3 Anti-Obesity Drugs (Anti-obesity Medication) by Application
1.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value by Application (2024 VS 2031)
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Estimates and Forecasts
1.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2020-2031
1.4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales 2020-2031
1.4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Obesity Drugs (Anti-obesity Medication) Market Competition by Manufacturers
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Obesity Drugs (Anti-obesity Medication), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Product Type & Application
2.7 Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Date of Enter into This Industry
2.8 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation and Trends
2.8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue
2.8.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Scenario by Region
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region: 2020-2031
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region: 2020-2025
3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region: 2026-2031
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2020-2031
3.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2020-2025
3.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2026-2031
3.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Country
3.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2031)
3.4.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Country
3.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2031)
3.5.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Country
3.7.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2031)
3.7.3 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2020-2031)
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2020-2025)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2026-2031)
4.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2031)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2020-2031)
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2020-2025)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2026-2031)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2020-2031)
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2020-2025)
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2026-2031)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2031)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2020-2031)
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2020-2025)
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2026-2031)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zafgan
6.1.1 Zafgan Company Information
6.1.2 Zafgan Description and Business Overview
6.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.1.5 Zafgan Recent Developments/Updates
6.2 Vivus
6.2.1 Vivus Company Information
6.2.2 Vivus Description and Business Overview
6.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.2.5 Vivus Recent Developments/Updates
6.3 Shionogi
6.3.1 Shionogi Company Information
6.3.2 Shionogi Description and Business Overview
6.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.3.5 Shionogi Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Rhythm Pharmaceuticals
6.5.1 Rhythm Pharmaceuticals Company Information
6.5.2 Rhythm Pharmaceuticals Description and Business Overview
6.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.5.5 Rhythm Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Orexigen Therapeutics
6.7.1 Orexigen Therapeutics Company Information
6.7.2 Orexigen Therapeutics Description and Business Overview
6.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.7.5 Orexigen Therapeutics Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Company Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Norgine
6.9.1 Norgine Company Information
6.9.2 Norgine Description and Business Overview
6.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.9.5 Norgine Recent Developments/Updates
6.10 Nalpropion Pharmaceuticals Inc.
6.10.1 Nalpropion Pharmaceuticals Inc. Company Information
6.10.2 Nalpropion Pharmaceuticals Inc. Description and Business Overview
6.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments/Updates
6.11 Merck
6.11.1 Merck Company Information
6.11.2 Merck Description and Business Overview
6.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.11.5 Merck Recent Developments/Updates
6.12 GlaxoSmithKline
6.12.1 GlaxoSmithKline Company Information
6.12.2 GlaxoSmithKline Description and Business Overview
6.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.12.5 GlaxoSmithKline Recent Developments/Updates
6.13 F.Hoffmann-La Roche
6.13.1 F.Hoffmann-La Roche Company Information
6.13.2 F.Hoffmann-La Roche Description and Business Overview
6.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.13.5 F.Hoffmann-La Roche Recent Developments/Updates
6.14 Eisai
6.14.1 Eisai Company Information
6.14.2 Eisai Description and Business Overview
6.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.14.5 Eisai Recent Developments/Updates
6.15 Boehringer Ingelheim
6.15.1 Boehringer Ingelheim Company Information
6.15.2 Boehringer Ingelheim Description and Business Overview
6.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.15.5 Boehringer Ingelheim Recent Developments/Updates
6.16 Bayer AG
6.16.1 Bayer AG Company Information
6.16.2 Bayer AG Description and Business Overview
6.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.16.5 Bayer AG Recent Developments/Updates
6.17 AstraZeneca
6.17.1 AstraZeneca Company Information
6.17.2 AstraZeneca Description and Business Overview
6.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.17.5 AstraZeneca Recent Developments/Updates
6.18 Arena Pharmaceuticals
6.18.1 Arena Pharmaceuticals Company Information
6.18.2 Arena Pharmaceuticals Description and Business Overview
6.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.18.5 Arena Pharmaceuticals Recent Developments/Updates
6.19 Amylin
6.19.1 Amylin Company Information
6.19.2 Amylin Description and Business Overview
6.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.19.5 Amylin Recent Developments/Updates
6.20 Alizyme
6.20.1 Alizyme Company Information
6.20.2 Alizyme Description and Business Overview
6.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Portfolio
6.20.5 Alizyme Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
7.2 Anti-Obesity Drugs (Anti-obesity Medication) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Obesity Drugs (Anti-obesity Medication) Production Mode & Process Analysis
7.4 Anti-Obesity Drugs (Anti-obesity Medication) Sales and Marketing
7.4.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Channels
7.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
7.5 Anti-Obesity Drugs (Anti-obesity Medication) Customer Analysis
8 Anti-Obesity Drugs (Anti-obesity Medication) Market Dynamics
8.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Trends
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
8.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
8.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zafgan
VIVUS
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer Inc
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
Eisai Co Ltd
Boehringer Ingelheim
Bayer
Astrazeneca plc
Arena Pharmaceuticals
Amylin
Alizyme
GlaxoSmithKline
GlaxoSmithKline PLC
F.Hoffmann-La Roche
List of Tables
 Table 1. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-Obesity Drugs (Anti-obesity Medication), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Product Type & Application
 Table 12. Global Key Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Application (2026-2031)
 Table 70. Zafgan Company Information
 Table 71. Zafgan Description and Business Overview
 Table 72. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 74. Zafgan Recent Developments/Updates
 Table 75. Vivus Company Information
 Table 76. Vivus Description and Business Overview
 Table 77. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 79. Vivus Recent Developments/Updates
 Table 80. Shionogi Company Information
 Table 81. Shionogi Description and Business Overview
 Table 82. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 84. Shionogi Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Rhythm Pharmaceuticals Company Information
 Table 91. Rhythm Pharmaceuticals Description and Business Overview
 Table 92. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 94. Rhythm Pharmaceuticals Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Orexigen Therapeutics Company Information
 Table 101. Orexigen Therapeutics Description and Business Overview
 Table 102. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 104. Orexigen Therapeutics Recent Developments/Updates
 Table 105. Novo Nordisk Company Information
 Table 106. Novo Nordisk Description and Business Overview
 Table 107. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 109. Novo Nordisk Recent Developments/Updates
 Table 110. Norgine Company Information
 Table 111. Norgine Description and Business Overview
 Table 112. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 114. Norgine Recent Developments/Updates
 Table 115. Nalpropion Pharmaceuticals Inc. Company Information
 Table 116. Nalpropion Pharmaceuticals Inc. Description and Business Overview
 Table 117. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 119. Nalpropion Pharmaceuticals Inc. Recent Developments/Updates
 Table 120. Merck Company Information
 Table 121. Merck Description and Business Overview
 Table 122. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 124. Merck Recent Developments/Updates
 Table 125. GlaxoSmithKline Company Information
 Table 126. GlaxoSmithKline Description and Business Overview
 Table 127. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 129. GlaxoSmithKline Recent Developments/Updates
 Table 130. F.Hoffmann-La Roche Company Information
 Table 131. F.Hoffmann-La Roche Description and Business Overview
 Table 132. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 134. F.Hoffmann-La Roche Recent Developments/Updates
 Table 135. Eisai Company Information
 Table 136. Eisai Description and Business Overview
 Table 137. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 139. Eisai Recent Developments/Updates
 Table 140. Boehringer Ingelheim Company Information
 Table 141. Boehringer Ingelheim Description and Business Overview
 Table 142. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 144. Boehringer Ingelheim Recent Developments/Updates
 Table 145. Bayer AG Company Information
 Table 146. Bayer AG Description and Business Overview
 Table 147. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 149. Bayer AG Recent Developments/Updates
 Table 150. AstraZeneca Company Information
 Table 151. AstraZeneca Description and Business Overview
 Table 152. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 154. AstraZeneca Recent Developments/Updates
 Table 155. Arena Pharmaceuticals Company Information
 Table 156. Arena Pharmaceuticals Description and Business Overview
 Table 157. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 159. Arena Pharmaceuticals Recent Developments/Updates
 Table 160. Amylin Company Information
 Table 161. Amylin Description and Business Overview
 Table 162. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 164. Amylin Recent Developments/Updates
 Table 165. Alizyme Company Information
 Table 166. Alizyme Description and Business Overview
 Table 167. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product
 Table 169. Alizyme Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
 Table 173. Anti-Obesity Drugs (Anti-obesity Medication) Customers List
 Table 174. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
 Table 175. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
 Table 176. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
 Table 177. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-Obesity Drugs (Anti-obesity Medication)
 Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type: 2024 & 2031
 Figure 4. by Drug Varieties Product Picture
 Figure 5. by Acting Product Picture
 Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application: 2024 & 2031
 Figure 8. Childhood (0-6)
 Figure 9. Juvenile (7-17)
 Figure 10. Youth (18-40)
 Figure 11. Middle Aged (41-60)
 Figure 12. Elderly (Above 60)
 Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (2020-2031) & (K Units)
 Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/Unit) & (2020-2031)
 Figure 17. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered
 Figure 18. Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2024
 Figure 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players: Market Share by Revenue in Anti-Obesity Drugs (Anti-obesity Medication) in 2024
 Figure 21. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2020-2031)
 Figure 24. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2031)
 Figure 36. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2031)
 Figure 57. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Application (2020-2031)
 Figure 60. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Application (2020-2031)
 Figure 61. Anti-Obesity Drugs (Anti-obesity Medication) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Anti obesity Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Control Medication Market Research Report 2024
Anti Obesity Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Obesity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Weight Loss Pills Market Research Report 2024
Peripherally Acting Anti Obesity Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long acting Weight Loss Drugs Market Research Report 2024
Global Diet Pill Market Insights Forecast to 2030
Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Loss Medicine Orlistat Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global Genetic Obesity Drug Market Research Report 2025
Antihyperlipidemic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Control Products Market Insights Forecast to 2030
Global Prescription Weight Loss Medications Market Research Report 2025
Global Oral Anorexiant Drug Market Research Report 2024
Global GLP 1 Weight Loss Pill Market Research Report 2024
Global Weight Loss Therapeutics Market Insights Forecast to 2030
Global Weight Loss Programs Market Research Report 2024
Global Medication for Hair Loss Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions